Ameya Kirtane
Ameya Kirtane
Brigham and Women's Hospital, Harvard Medical School
Verified email at - Homepage
Cited by
Cited by
Nanotechnology approaches for global infectious diseases
AR Kirtane, M Verma, P Karandikar, J Furin, R Langer, G Traverso
Nature Nanotechnology 16 (4), 369-384, 2021
Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities
AR Kirtane, SM Kalscheuer, J Panyam
Advanced drug delivery reviews 65 (13-14), 1731-1747, 2013
Folic acid functionalized nanoparticles for enhanced oral drug delivery
E Roger, S Kalscheuer, A Kirtane, BR Guru, AE Grill, J Whittum-Hudson, ...
Molecular pharmaceutics 9 (7), 2103-2110, 2012
Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
AR Kirtane, O Abouzid, D Minahan, T Bensel, AL Hill, C Selinger, ...
Nature communications 9 (1), 1-12, 2018
Triggerable tough hydrogels for gastric resident dosage forms
J Liu, Y Pang, S Zhang, C Cleveland, X Yin, L Booth, J Lin, YA Lucy Lee, ...
Nature communications 8 (1), 124, 2017
Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer …
S Arora, SK Swaminathan, A Kirtane, SK Srivastava, A Bhardwaj, S Singh, ...
International journal of nanomedicine, 2933-2942, 2014
3D‐printed gastric resident electronics
YL Kong, X Zou, CA McCandler, AR Kirtane, S Ning, J Zhou, A Abid, ...
Advanced Materials Technologies 4 (3), 1800490, 2019
Computationally guided high-throughput design of self-assembling drug nanoparticles
D Reker, Y Rybakova, AR Kirtane, R Cao, JW Yang, N Navamajiti, ...
Nature nanotechnology 16 (6), 725-733, 2021
Weighing up gene delivery
AR Kirtane, J Panyam
Nature nanotechnology 8 (11), 805-806, 2013
Temperature-responsive biometamaterials for gastrointestinal applications
S Babaee, S Pajovic, AR Kirtane, J Shi, E Caffarel-Salvador, K Hess, ...
Science translational medicine 11 (488), eaau8581, 2019
Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections
A Abramson, AR Kirtane, Y Shi, G Zhong, JE Collins, S Tamang, K Ishida, ...
Matter 5 (3), 975-987, 2022
Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling
JM Song, K Molla, A Anandharaj, I Cornax, MG OSullivan, AR Kirtane, ...
Oncotarget 8 (16), 26927, 2017
Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant–polymer nanoparticles
M Usacheva, SK Swaminathan, AR Kirtane, J Panyam
Molecular pharmaceutics 11 (9), 3186-3195, 2014
Genotype-targeted local therapy of glioma
GM Shankar, AR Kirtane, JJ Miller, H Mazdiyasni, J Rogner, T Tai, ...
Proceedings of the National Academy of Sciences 115 (36), E8388-E8394, 2018
Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form
DH Altreuter, AR Kirtane, T Grant, C Kruger, G Traverso, AM Bellinger
Expert opinion on drug delivery 15 (12), 1189-1198, 2018
Machine learning uncovers food-and excipient-drug interactions
D Reker, Y Shi, AR Kirtane, K Hess, GJ Zhong, E Crane, CH Lin, ...
Cell reports 30 (11), 3710-3716. e4, 2020
Gastrointestinal synthetic epithelial linings
J Li, T Wang, AR Kirtane, Y Shi, A Jones, Z Moussa, A Lopes, J Collins, ...
Science translational medicine 12 (558), eabc0441, 2020
A once-a-month oral contraceptive
AR Kirtane, T Hua, A Hayward, A Bajpayee, A Wahane, A Lopes, ...
Science Translational Medicine 11 (521), eaay2602, 2019
Local targeting of NAD+ salvage pathway alters the immune tumor microenvironment and enhances checkpoint immunotherapy in glioblastoma
M Li, AR Kirtane, J Kiyokawa, H Nagashima, A Lopes, ZA Tirmizi, CK Lee, ...
Cancer research 80 (22), 5024-5034, 2020
Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer
V Khanna, S Kalscheuer, A Kirtane, W Zhang, J Panyam
Future drug discovery 1 (1), FDD8, 2019
The system can't perform the operation now. Try again later.
Articles 1–20